ICICI Prudential Nifty Pharma Index Fund
NAV
₹20.56
as of 6 Oct 2026
ICICI Prudential Nifty Pharma Index Fund is an open-ended Index Funds scheme from ICICI Prudential Mutual Fund managing ₹157 crore (as of 31 Aug 2026). Its Direct-plan NAV is ₹20.56 as of 6 Oct 2026. The expense ratio is 0.52% a year. Managed by Nishit Patel. This page is factual data only – it carries no rating and no recommendation.
Key facts
- Expense ratio
- 0.52% / yr
- as of 31 Aug 2026
- Fund size
- ₹157 crore
- as of 31 Aug 2026
- Exit load
- None
- SIP available
- Yes
- Launched
- 15 Dec 2022
- ISIN
- INF109KC11M9
₹100 invested, fund vs category
The category line is the average of the funds in this category, built from nyvo’s own NAV data.
Rebased to 100data to 5 Oct 2026Benchmark: Nifty Pharma
ICICI Prudential Nifty Pharma Index Fund
₹203
+103% on ₹100 over 3.8 yrs
Index Funds average
₹168
+68% on ₹100 over 3.8 yrs
Returns vs category
| Window | Fund | Category avg | Gap |
|---|---|---|---|
| 3 months | 1.81% | -1.84% | +3.65 |
| 6 months | 18.91% | 15.24% | +3.67 |
| 1 year | 20.05% | 13.84% | +6.21 |
| 3 years (CAGR) | 20.05% | 19.84% | +0.21 |
No category average is available for this fund. Short windows are noise; the 3 and 5-year rows are the record. Past returns do not predict future returns.
A single return number depends on its start date. These are ALL the overlapping holding periods, so the worst case is visible – read that number first.
1-year holding periods
- Worst
- -6.5%
- Median
- 19.6%
- Best
- 58.8%
35 windows over the last 46 months, stepped monthly; 89% ended positive. Worst window began 1 Oct 2024. Windows overlap – this is the range of past start dates, not a probability of anything.
3-year holding periods (per year)
- Worst
- 19.9%
- Median
- 21.6%
- Best
- 24.7%
11 windows over the last 46 months, stepped monthly; 100% ended positive. Worst window began 3 Oct 2023. Windows overlap – this is the range of past start dates, not a probability of anything.
Risk, measured
- Sharpe ratio (3Y)
- 0.93
- Sortino ratio (3Y)
- 1.58
- Standard deviation (3Y)
- 15.96%
Distance below its own peak
Every dip below 0 is the fund trading under a previous high – how deep and for how long is what a drawdown feels like.
Deepest fall
-15.2%
Right now
-4.0% below peak
Where the money actually is
Equity
99.9%
Cash
0.1%
Whole-portfolio split, as of 31 Aug 2026. The size split below covers only the equity slice of this.
What it owns
22 positions · top 10 = 78.8%
Market-cap mix (equity sleeve)
Large 47.8%Mid 45.0%Small 7.1%Other 0.1%
as of 31 Aug 2026
Holdings by sector
Healthcare(10 in top 10)99.9%
- Sun Pharmaceuticals Industries Ltd20.76%
- Divi's Laboratories Ltd11.88%
- Cipla Ltd7.83%
- Laurus Labs Ltd7.36%
- Torrent Pharmaceuticals Ltd7.34%
- Dr Reddy's Laboratories Ltd6.95%
- Lupin Ltd5.25%
- Aurobindo Pharma Ltd4.69%
- Glenmark Pharmaceuticals Ltd3.69%
- Alkem Laboratories Ltd3.08%
Sectors marked ▶ expand to show this fund’s top-10 holdings in that sector. Holdings as of 31 Aug 2026. Portfolio turnover 86.0% vs category 33.7% a year.
Money in, money out
- Net flow, 12 months
- +₹41 cr
- Net flow, 3 months
- +₹11 cr
as of 31 Aug 2026. Flows follow performance more than they predict it.
Quick answers
- What is the NAV of ICICI Prudential Nifty Pharma Index Fund?
- ₹20.56 per unit as of 6 Oct 2026 (Direct plan, growth). NAV is declared daily on working days.
- What is the expense ratio of ICICI Prudential Nifty Pharma Index Fund?
- 0.52% a year for the Direct plan, as of 31 Aug 2026.
- How large is ICICI Prudential Nifty Pharma Index Fund?
- ₹157 crore under management as of 31 Aug 2026, in the Index Funds category.
- How risky is ICICI Prudential Nifty Pharma Index Fund?
- Its SEBI Riskometer reading is "Very High Risk". Own the whole market, pay almost nothing. A great deal of the ETF money is EPFO's.
- What is the worst 3-year return of ICICI Prudential Nifty Pharma Index Fund?
- 19.9% a year – the weakest of 11 overlapping 3-year holding periods, beginning 3 Oct 2023. The median was 21.6% and 100% of those windows ended positive. Windows overlap, so this is the range of past start dates, not a probability.
- Who manages ICICI Prudential Nifty Pharma Index Fund?
- Nishit Patel, managing this fund for 3.7 years.
Where this fund sits
Its shelf, all funds
Ix · Index funds & ETFs →
Own the whole market, pay almost nothing. A great deal of the ETF money is EPFO's.
The money map
How big this shelf is in India →
The whole industry sized by real money, from AMFI’s monthly data.
Side by side
Compare this fund →
Put it next to any other fund – growth, returns, risk and cost in one table.
One bet or two?
Check its overlap →
See whether it owns the same stocks as your other funds.
Other Index Funds funds
- UTI Nifty 50 Index Fund₹29,485 crore
- HDFC Nifty 50 Index Fund₹23,784 crore
- ICICI Prudential Nifty 50 Index Fund₹17,254 crore
- ICICI Prudential Nifty Next 50 Index Fund₹10,117 crore
- HDFC Nifty G-Sec Apr 2029 Index Fund₹161 crore
- HDFC Nifty India Digital Index Fund₹158 crore
- UTI Nifty50 Equal Weight Index Fund₹154 crore
- Aditya Birla Sun Life CRISIL IBX SDL Jun 2032 Index Fund₹151 crore
Data: nyvo research systems; each block above states its own as-of date, and blocks with no data for this fund are omitted rather than estimated. NAV updates daily on working days. The benchmark (Nifty Pharma) is named for reference only; its values are licensed and never shown. This page is factual information about one scheme. It is not investment advice, not a recommendation, and it carries no rating of any kind. Past performance does not predict future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.